Adriaan Hart de Ruijter

Dr. Hart de Ruijter is an investor and entrepreneur in life science with over twenty-seven years of experience in the industry. After a start in clinical research at Sanofi, he founded MSOURCE, the contract research organization, in 1994.

After selling to TÜV SÜD in 2008, he started to invest in biotechnology and medical device start-ups with a focus on the early stage. Cascara Ventures is his second fund, which started in 2016. He is on the board of several life science companies.

His particular interests are to collaborate with excellent teams, work on promising scientific breakthroughs and create meaningful improvements to healthcare. He also holds an MD from Leiden University and an MBA from Erasmus University in the Netherlands.